Chargement en cours...
Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) reported to show a higher efficacy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) than other TKIs. However, few studies describe ponatinib for pediatric Ph+ALL; therefore, the efficacy, safety, and opti...
Enregistré dans:
| Publié dans: | Case Rep Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger AG
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983555/ https://ncbi.nlm.nih.gov/pubmed/33776678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511071 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|